Xiaohua Pei Selected Research

tetrandrine

1/2020	JNK and Autophagy Independently Contributed to Cytotoxicity of Arsenite combined With Tetrandrine via Modulating Cell Cycle Progression in Human Breast Cancer Cells.
1/2020	Radix Stephaniae Tetrandrine: An Emerging Role for Management of Breast Cancer.
1/2019	Differentiation induction of human breast cancer cells by arsenite in combination with tetrandrine.
1/2019	Tetrandrine-Induced Autophagy in MDA-MB-231 Triple-Negative Breast Cancer Cell through the Inhibition of PI3K/AKT/mTOR Signaling.
1/2018	Antitumor activity of arsenite in combination with tetrandrine against human breast cancer cell line MDA-MB-231 in vitro and in vivo.
8/2017	Synergistic cytotoxic effects of arsenite and tetrandrine in human breast cancer cell line MCF-7.
8/2017	Tetrandrine and arsenic trioxide synergistically inhibit proliferation of HCC1937 triple negative breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaohua Pei Research Topics

Disease

7	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2017
6	Neoplasms (Cancer) 01/2020 - 08/2017
4	Chronic Renal Insufficiency 08/2015 - 01/2014
3	Triple Negative Breast Neoplasms 01/2019 - 08/2017
2	Pain (Aches) 06/2014 - 10/2013
1	Osteoporosis 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Inflammation (Inflammations) 01/2020
1	Necrosis 01/2020
1	Cognitive Dysfunction 01/2019
1	Lymphedema (Milroy Disease) 01/2019
1	Fatigue 01/2019
1	Breast Cancer Lymphedema 01/2019
1	Acute Promyelocytic Leukemia 01/2018
1	Bone Resorption 01/2017
1	Acute Kidney Injury (Acute Renal Failure) 01/2017
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Kidney Diseases (Kidney Disease) 09/2015
1	Subacute Thyroiditis (Thyroiditis, De Quervain) 06/2014
1	Goiter 06/2014
1	Fever (Fevers) 06/2014
1	Hypothyroidism 06/2014
1	Mastodynia 10/2013
1	Hyperplasia 10/2013
1	Renal Insufficiency (Renal Failure) 03/2013
1	Proteinuria 07/2012
1	Infections 01/2011

Drug/Important Bio-Agent (IBA)

7	tetrandrineIBA 01/2020 - 08/2017
5	Cystatin CIBA 01/2017 - 01/2014
5	CreatinineIBA 01/2014 - 07/2012
4	arseniteIBA 01/2020 - 08/2017
3	Pharmaceutical PreparationsIBA 01/2020 - 10/2013
3	ArsenicIBA 01/2020 - 08/2017
2	AlkaloidsIBA 01/2020 - 08/2017
1	CateninsIBA 01/2021
1	cinnamaldehyde (cinnamic aldehyde)FDA Link 01/2020
1	fangchinoline (limacine)IBA 01/2020
1	pyrazolanthroneIBA 01/2020
1	WortmanninIBA 01/2020
1	Cadherins (E-Cadherin)IBA 01/2020
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2020
1	Beclin-1IBA 01/2019
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2019
1	Cyclin D1IBA 01/2018
1	Estrogen ReceptorsIBA 01/2018
1	Arsenic Trioxide (Trisenox)FDA Link 08/2017
1	Proteins (Proteins, Gene)FDA Link 08/2017
1	brucineIBA 01/2017
1	Prednisone (Sone)FDA LinkGeneric 06/2014
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 06/2014
1	Hormones (Hormone)IBA 06/2014
1	Urea (Carbamide)FDA LinkGeneric 07/2012
1	NitrogenIBA 07/2012
1	Uric Acid (Urate)IBA 07/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2011

Therapy/Procedure

5	Therapeutics 01/2019 - 03/2013
2	Aftercare (After-Treatment) 01/2019 - 10/2013
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2020
1	Radiotherapy 01/2020
1	Renal Dialysis (Hemodialysis) 01/2019
1	Moxibustion 01/2019